Healthcare is undergoing a profound transformation. Ageing populations, rising expectations and advances in medical science are driving sustained global demand for diagnostic and therapeutic technologies.
From early disease detection to critical care, the focus is shifting towards faster innovation, greater accessibility and higher standards of safety and reliability. IMI’s precision-engineered components sit at the heart of this evolution.
The systems our customers build protect or even save lives. Our role is to ensure they operate with absolute precision because in healthcare, there is no margin for error.
Invisible components, vital performance
IMI’s miniature valves, fluid control systems operate largely out of sight, within a wide range of medical devices to manage the flow of gases and liquids in clinical and laboratory settings. These components support the accuracy and consistency that modern healthcare relies on, from delivering precision gas control in respiratory and anaesthesia to enabling precise liquid handling in diagnostic and analytical equipment.
In life-critical environments, dependable performance is essential. IMI’s technologies are designed to operate reliably in demanding conditions, supporting consistent device operation where precision and control are vital for instrument operation.
Enabling faster, smarter innovation
Healthcare innovation depends on both precision and scalability. IMI works closely with global medical device manufacturers from concept through to production, helping shorten development cycles, validate new technologies and bring systems to market efficiently. Through custom sub-assemblies and co-engineered fluidic modules, we help simplify system design and support scalable manufacturing, while meeting regulatory and quality requirements. Continued investment in digital integration and valve technology will support next generation devices. These capabilities will help enable a more data-driven, personalised approach to care.
How we win: from purpose to growth
IMI’s Healthcare exposure demonstrates how purpose and performance align. By enabling devices that improve diagnosis, treatment and patient outcomes, we address a long-term growth market that expands independently of the economic cycle. Our technologies support this demand from inside the system, unseen but indispensable, translating engineering excellence into measurable social and financial value.
Find out more about our growth opportunities in the Life Science sector here
